Aryl Hydrocarbon Interacting Protein Like 1 (AIPL1) Antibody

Este producto es parte de AIP -Aryl-hydrocarbon-interacting protein (like 1)
Product Graph
637€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Aryl Hydrocarbon Interacting Protein Like 1 (AIPL1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx111074
tested applications
ELISA, WB, IHC

Description

Aryl Hydrocarbon Receptor Interacting Protein-Like 1 Antibody is a Rabbit Polyclonal antibody against Aryl Hydrocarbon Receptor Interacting Protein-Like 1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Aryl Hydrocarbon Interacting Protein Like 1 (AIPL1)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.3, containing 0.02% Sodium Azide and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9NZN9
Gene ID
23746
NCBI Accession
NM_014336.4
OMIM
604392
Alias
AIPL2, LCA4
Background
Antibody anti-AIPL1
Status
RUO

Descripción

AIPL1 is a specialized molecular chaperone predominantly expressed in retinal photoreceptor cells, where it plays a crucial role in the folding, stability, and assembly of proteins essential for phototransduction. Structurally, AIPL1 contains tetratricopeptide repeat (TPR) domains, which mediate protein-protein interactions, and a FKBP-like domain, enabling its chaperone activity. AIPL1 is critical for the proper function of phosphodiesterase 6 (PDE6), a key enzyme in the visual cycle. It helps stabilize PDE6 subunits during their assembly, ensuring efficient phototransduction signaling. Mutations in the AIPL1 gene are associated with severe retinal degenerative diseases, including Leber congenital amaurosis type 4 (LCA4) and retinitis pigmentosa (RP). These conditions result from impaired PDE6 function, leading to photoreceptor cell death and progressive vision loss. Due to its specific expression in photoreceptors and essential role in their survival, AIPL1 is a target of interest for gene therapy and retinal disease research.

Related Products

FNab00240

AIPL1 antibody

May be important in protein trafficking and/or protein folding and stabilization.

Ver Producto
P9872

Recombinant Human AIPL1

Ver Producto
abx004950

Aryl Hydrocarbon Interacting Protein Like 1 (AIPL1) Antibody

AIPL1 Antibody is a Rabbit Polyclonal antibody against AIPL1. Leber congenital amaurosis (LCA) is the most severe inherited retinopathy with the earliest age of onset and accounts for at least 5% of all inherited retinal diseases. Affected individuals are diagnosed at birth or in the first few months of life with nystagmus, severely impaired vision or blindness and an abnormal or flat electroretinogram. The photoreceptor/pineal-expressed gene, AIPL1, encoding aryl-hydrocarbon interacting protein-like 1, is located within the LCA4 candidate region. The encoded protein contains three tetratricopeptide motifs, consistent with chaperone or nuclear transport activity. Mutations in this gene may cause approximately 20% of recessive LCA. Alternative splicing results in multiple transcript variants.

Ver Producto